Streptococcal toxic shock syndrome due to Streptococcus dysgalactiae subsp. equisimilis from retroperitoneal panniculitis during the treatment with anti-IL-6 receptor antibody: A case report

Sho Fujimoto; Yoshihiro Eriguchi; Rinto Nakamura; Sota Kamikawa; Akiko Yonekawa; Noriko Miyake; Nobuyuki Ono; Hiroaki Niiro

doi:10.1093/mrcr/rxae001

Streptococcal toxic shock syndrome due to Streptococcus dysgalactiae subsp. equisimilis from retroperitoneal panniculitis during the treatment with anti-IL-6 receptor antibody: A case report

Sho Fujimoto, Yoshihiro Eriguchi, Rinto Nakamura, Sota Kamikawa, Akiko Yonekawa, Noriko Miyake, Nobuyuki Ono, Hiroaki Niiro

研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

抄録

A 53-year-old man with adult-onset Still’s disease developed severe streptococcal toxic shock syndrome (STSS) due to Streptococcus dysgalactiae subsp. equisimilis (SDSE), following retroperitoneal panniculitis. He was receiving tocilizumab (TCZ), an interleukin-6 receptor inhibitor. The modifying effect of TCZ on the immune response and the pathophysiology of SDSE infection may have led to retroperitoneal panniculitis and atypical STSS with delayed shock and flare of soft tissue inflammation.

本文言語	英語
ページ（範囲）	255-258
ページ数	4
ジャーナル	Modern Rheumatology Case Reports
巻	8
号	2
DOI	https://doi.org/10.1093/mrcr/rxae001
出版ステータス	出版済み - 7月 1 2024

!!!All Science Journal Classification (ASJC) codes

リウマチ学

文献へのアクセス

10.1093/mrcr/rxae001

他のファイルとリンク

フィンガープリント

「Streptococcal toxic shock syndrome due to Streptococcus dysgalactiae subsp. equisimilis from retroperitoneal panniculitis during the treatment with anti-IL-6 receptor antibody: A case report」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Fujimoto, S., Eriguchi, Y., Nakamura, R., Kamikawa, S., Yonekawa, A., Miyake, N., Ono, N., & Niiro, H. (2024). Streptococcal toxic shock syndrome due to Streptococcus dysgalactiae subsp. equisimilis from retroperitoneal panniculitis during the treatment with anti-IL-6 receptor antibody: A case report. Modern Rheumatology Case Reports, 8(2), 255-258. https://doi.org/10.1093/mrcr/rxae001

Streptococcal toxic shock syndrome due to Streptococcus dysgalactiae subsp. equisimilis from retroperitoneal panniculitis during the treatment with anti-IL-6 receptor antibody: A case report. / Fujimoto, Sho ; Eriguchi, Yoshihiro; Nakamura, Rinto その他.
In: Modern Rheumatology Case Reports, Vol. 8, No. 2, 01.07.2024, p. 255-258.

研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Fujimoto, S , Eriguchi, Y, Nakamura, R, Kamikawa, S, Yonekawa, A, Miyake, N, Ono, N & Niiro, H 2024, 'Streptococcal toxic shock syndrome due to Streptococcus dysgalactiae subsp. equisimilis from retroperitoneal panniculitis during the treatment with anti-IL-6 receptor antibody: A case report', Modern Rheumatology Case Reports, vol. 8, no. 2, pp. 255-258. https://doi.org/10.1093/mrcr/rxae001

@article{2e602bd4a8ce4566aef1192d7f3d7fe9,

title = "Streptococcal toxic shock syndrome due to Streptococcus dysgalactiae subsp. equisimilis from retroperitoneal panniculitis during the treatment with anti-IL-6 receptor antibody: A case report",

abstract = "A 53-year-old man with adult-onset Still{\textquoteright}s disease developed severe streptococcal toxic shock syndrome (STSS) due to Streptococcus dysgalactiae subsp. equisimilis (SDSE), following retroperitoneal panniculitis. He was receiving tocilizumab (TCZ), an interleukin-6 receptor inhibitor. The modifying effect of TCZ on the immune response and the pathophysiology of SDSE infection may have led to retroperitoneal panniculitis and atypical STSS with delayed shock and flare of soft tissue inflammation.",

keywords = "Streptococcal toxic shock syndrome, streptococcus dysgalactiae subsp. equisimilis, tocilizumab, β-hemolytic streptococcus",

author = "Sho Fujimoto and Yoshihiro Eriguchi and Rinto Nakamura and Sota Kamikawa and Akiko Yonekawa and Noriko Miyake and Nobuyuki Ono and Hiroaki Niiro",

year = "2024",

month = jul,

day = "1",

doi = "10.1093/mrcr/rxae001",

language = "English",

volume = "8",

pages = "255--258",

journal = "Modern Rheumatology Case Reports",

issn = "2472-5625",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Streptococcal toxic shock syndrome due to Streptococcus dysgalactiae subsp. equisimilis from retroperitoneal panniculitis during the treatment with anti-IL-6 receptor antibody

T2 - A case report

AU - Fujimoto, Sho

AU - Eriguchi, Yoshihiro

AU - Nakamura, Rinto

AU - Kamikawa, Sota

AU - Yonekawa, Akiko

AU - Miyake, Noriko

AU - Ono, Nobuyuki

AU - Niiro, Hiroaki

PY - 2024/7/1

Y1 - 2024/7/1

N2 - A 53-year-old man with adult-onset Still’s disease developed severe streptococcal toxic shock syndrome (STSS) due to Streptococcus dysgalactiae subsp. equisimilis (SDSE), following retroperitoneal panniculitis. He was receiving tocilizumab (TCZ), an interleukin-6 receptor inhibitor. The modifying effect of TCZ on the immune response and the pathophysiology of SDSE infection may have led to retroperitoneal panniculitis and atypical STSS with delayed shock and flare of soft tissue inflammation.

AB - A 53-year-old man with adult-onset Still’s disease developed severe streptococcal toxic shock syndrome (STSS) due to Streptococcus dysgalactiae subsp. equisimilis (SDSE), following retroperitoneal panniculitis. He was receiving tocilizumab (TCZ), an interleukin-6 receptor inhibitor. The modifying effect of TCZ on the immune response and the pathophysiology of SDSE infection may have led to retroperitoneal panniculitis and atypical STSS with delayed shock and flare of soft tissue inflammation.

KW - Streptococcal toxic shock syndrome

KW - streptococcus dysgalactiae subsp. equisimilis

KW - tocilizumab

KW - β-hemolytic streptococcus

UR - http://www.scopus.com/inward/record.url?scp=85198245426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85198245426&partnerID=8YFLogxK

U2 - 10.1093/mrcr/rxae001

DO - 10.1093/mrcr/rxae001

M3 - Article

C2 - 38217091

AN - SCOPUS:85198245426

SN - 2472-5625

VL - 8

SP - 255

EP - 258

JO - Modern Rheumatology Case Reports

JF - Modern Rheumatology Case Reports

IS - 2

ER -